4.24 +0.07 (1.66%)
SNTA
Stock Details
Last Trade:4.24 Change:+0.07 (1.66%) Prev Close:4.17 Open: 4.22 Days Range:4.12 – 4.32 52 Week Range: 1.20 - 9.07 Volume:338061 P/E: 2.40EPS:1.77
View AllRecent Alerts 02/09/10
Recent Alert on 02/08/10 at 7:41am
Synta Pharma (SNTA) Preclinical Shows STA-9090 Inhibits Wilms' Tumor 1 Protein
Synta Pharma (SNTA) Preclinical Shows STA-9090 Inhibits Wilms' Tumor 1 Protein
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that preclinical results presented at the "Bridging the Gap 2010" Hematologic Conference, held in Singapore City, Singapore, February 5-7, 2010, shows that STA-9090, a potent inhibitor of... Read More
Recent Alert on 02/08/10 at 7:41am
Synta Pharma (SNTA) Preclinical Shows STA-9090 Inhibits Wilms' Tumor 1 Protein
Synta Pharma (SNTA) Preclinical Shows STA-9090 Inhibits Wilms' Tumor 1 Protein
Recent Alert on 01/19/10 at 9:01am
Synta Pharma (SNTA) Sells 833K of Additional Common for $4.50/Share
Synta Pharma (SNTA) Sells 833K of Additional Common for $4.50/Share
Recent Alert on 01/19/10 at 9:01am
Synta Pharma (SNTA) Sells 833K of Additional Common for $4.50/Share
Synta Pharma (SNTA) Sells 833K of Additional Common for $4.50/Share
Recent Alert on 01/08/10 at 12:22pm
Unusual 11 Mid-Day Movers 01/08: AEN, SPDE, CYCC, HTX Higher; SNTA, ROG, EMMS, AZZ Lower
Unusual 11 Mid-Day Movers 01/08: AEN, SPDE, CYCC, HTX Higher; SNTA, ROG, EMMS, AZZ Lower
View AllRecent Press Releases
Press Release on 02/08/10 at 7:30am
Synta Announces STA-9090 Results Demonstrating Potent in vitro and in vivo Activity in AML
Synta Announces STA-9090 Results Demonstrating Potent in vitro and in vivo Activity in AML
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 09/20/09 at 4:50pm
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers